Skip to main content
Premium Trial:

Request an Annual Quote

Yourgene Health to Manufacture Coronavirus Test for Novacyt

NEW YORK – Yourgene Health said on Wednesday that it has signed an agreement with Novacyt to provide contract manufacturing services for Novacyt's COVID-19 diagnostic test.

Under the agreement, UK-based Yourgene will use its manufacturing facility at Citylabs in Manchester to ramp up production of the test, which was developed by Primerdesign, Novacyt's molecular diagnostics division. The assay has received CE marking and US Food and Drug Administration Emergency Use Authorization.

Yourgene expects to ship the first batches of the test over the next few weeks. Initially, the company will manufacture "critical components" for the test, which is PCR based, while maintaining production of its own tests. The firms may expand their agreement in the future to have Yourgene produce the entire COVID-19 testing kit.

Financial details of the deal were not disclosed.

In addition to support manufacturing of Novacyt's test, Yourgene is in the process of expanding its lab capabilities to support the UK's National Health Service by providing COVID-19 laboratory testing services.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.